Although this finding might be related to the effect of JAK–STAT pathway inhibition on mechanisms involved in insulin resistance and β-cell dysfunction in DM, further studies are needed to reproduce these findings and shed light on potential underlying mechanisms. The gene discussed is INS; the disease is diabetes mellitus.